Fig. 2From: Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history studyA HQ-CT Change from Baseline Comparison of C601/C602 to PATH for PWS at 26 Weeks and 52 Weeks; and 2B. Prader-Willi Syndrome Profile Domain Change from Baseline Comparison of C601/C602 to PATH for PWS at 26 WeeksBack to article page